Worldwide

Featured Stock to Focus: Editas Medicine Inc. (EDIT)

Editas Medicine, Inc. (NASDAQ:EDIT) has declined 45.48% since February 3, 2017 and is downtrending. There are brokerage firms with lower targets than the average, including one setting a price target of $27. The company's Relative Strength Index which shows price strength now stands at 58.65. SunTrust Banks also issued estimates for Editas Medicine's FY2019 earnings at ($3.08) EPS, FY2020 earnings at ($3.33) EPS, FY2021 earnings at ($3.33) EPS and FY2022 earnings at ($3.57) EPS.

Several other equities research analysts also recently weighed in on the company.

Editas Medicine, Inc. (EDIT) exchanged hands at an unexpectedly high level of 2.5 million shares over the course of the day. ValuEngine upgraded shares of Editas Medicine from a "sell" rating to a "hold" rating in a research note on Saturday, September 30th. BidaskClub upgraded Editas Medicine from a "buy" rating to a "strong-buy" rating in a research note on Tuesday. The scale runs from 1 to 5 with 1 recommending Strong Buy and 5 recommending a Strong Sell. After keeping Technical check on movement of stock price comparison to its moving averages like 20, 50 and 200 SMA, we detected following trends of EDIT.

Shares of Editas Medicine (EDIT) traded down $1.77 during trading on Wednesday, reaching $34.80. Overall, the share price is up 12.18% so far this year.

Shares of Editas Medicine Cmn (NASDAQ:EDIT) now have an Average Brokerage Recommendation of 2, number of Recs in ABR is 6 while industry rank of the company by ABR is 194 out of 265.

Whereas they predicted High and Low Earnings Estimate as $-0.52 and $-1.36 respectively. The stock has a market cap of $1,730.00 and a price-to-earnings ratio of -12.12.

Editas Medicine (NASDAQ:EDIT) last announced its quarterly earnings results on Tuesday, November 7th. The company reported ($0.64) EPS for the quarter, missing the Zacks' consensus estimate of ($0.60) by ($0.04). During the same quarter a year ago, the business earned ($0.59) EPS. Oppenheimer Holdings, Inc. reiterated a "market perform" rating on shares of Editas Medicine in a research report on Tuesday, July 18th.

In other news, insider Katrine Bosley sold 8,333 shares of the company's stock in a transaction that occurred on Friday, December 1st. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.

In related news, CFO Andrew A.F. Hack sold 5,000 shares of the firm's stock in a transaction that occurred on Friday, November 17th. The shares were sold at an average price of $38.79, for a total transaction of $775,800.00. Following the completion of the transaction, the chief financial officer now directly owns 5,000 shares in the company, valued at $124,050. The disclosure for this sale can be found here. The Firm has ATR of 2.86 that is explaining range of a day's trading is high-low; ATR expands it to yesterday's closing price if it was outside of latest range.

Hedge funds have recently bought and sold shares of the stock. State Street Corp boosted its holdings in Editas Medicine by 305.4% in the second quarter. Shares are now up over the past year, outperforming the broad market by -100% and outperformed a peer group of similar companies by 178%. Editas Medicine Cmn (NASDAQ:EDIT) has trailing twelve month Return on Assets of -37.1%, which is key indicator of how profitable a company is relative to its total assets. Ark Investment Management LLC boosted its position in shares of Editas Medicine by 121.9% in the second quarter. Global Thematic Partners LLC now owns 614,052 shares of the company's stock valued at $18,869,000 after acquiring an additional 49,011 shares during the period. Finally, Northern Trust Corp raised its position in shares of Editas Medicine by 245.9% in the second quarter. Northern Trust Corp now owns 373,149 shares of the company's stock worth $6,261,000 after buying an additional 265,273 shares in the last quarter. State Street Corp now owns 537,640 shares of the company's stock valued at $9,022,000 after buying an additional 405,022 shares during the last quarter. Company insiders own 19.40% of the company's stock.

ILLEGAL ACTIVITY WARNING: This article was originally published by Week Herald and is the property of of Week Herald. If you are accessing this story on another publication, it was copied illegally and republished in violation of US & worldwide trademark & copyright legislation.

While having a peek at profitability ratios Editas Medicine Cmn (NASDAQ:EDIT) has trailing twelve month gross margin at 0%, its trailing twelve month operating margin stands at 0% whereas its trailing twelve month net profit margin spots at 0%.



Like this

loading...
loading...

Latest


12 April 2018
New Jersey Looking Towards Sports Betting
New Jersey has demonstrated recently that financial returns from legalising gambling, in particular online gambling can be huge . As of April 2018 New Jersey have spent a massive $7.2M dollars in the fight to legalise sports betting within the state borders.

15 March 2018
Server Requirements for Mass Mailing
The first means that the error occurred on the receiving side: maybe the client's account was blocked, or something else happened. Running your own email server may sound like a science fiction, and it may seem that it’s impossible to handle such thing.

04 February 2018
$165K In Jewelry Stolen From John Stamos' Fiancée On Eve Of Wedding
Now, will her wedding outfit be bereft of fancy jewelry? Authorities told TMZ that was no sign of forced entry. At the time, Stamos also revealed that he had accelerated his wedding plans because of McHugh's pregnancy.

04 February 2018
Microsoft could launch Windows 10 Home "S Mode"
Dona Sarkar has just announced that there won't be any new Windows 10 Insider build today (February 2nd) due to a rollback situation.

03 February 2018
Analysts Recommendations Annaly Capital Management, Inc. (NLY)
Finally, Advisor Partners LLC bought a new position in Annaly Capital Management in the 4th quarter worth approximately $122,000. Further, company shares have been seen trading -4.00% off of the 52 week high and 28.45% away from the 52 week low.

03 February 2018
Man killed in multi-car crash in the Bronx, police say
Police say a 31-year-old man is dead and another is in police custody after a fatal auto accident overnight on Burke Avenue. The driver of the second vehicle that was struck, a 48-year-old woman, was also taken to the hospital in stable condition.

03 February 2018
Creative Planning Raises Holdings in Laboratory Corp. of America Holdings (NYSE:LH)
It turned negative, as 41 investors sold LH shares while 239 reduced holdings. 70 funds opened positions while 181 raised stakes. ValuEngine upgraded shares of Laboratory Corp. of America from a "hold" rating to a "buy" rating in a research report on Friday.

03 February 2018
Colorado State Head Coach Larry Eustachy Placed On Administrative Leave, Per Reports
The university's current investigation is based on similar concerning behavior by Eustachy, sources have told the Reporter-Herald. The university looked into Eustachy in 2013-14 for creating an atmosphere of "fear and intimidation" among his players.

03 February 2018
Investors Buy iShares Barclays TIPS Bond Fund (TIP) on Weakness
A reading under 20 would indicate no trend, and a reading from 20-25 would suggest that there is no clear trend signal. The Williams %R indicator helps show the relative situation of the current price close to the period being observed.

03 February 2018
Teck Resources Plans Dividend of $0.04 (TECK)
Teck Resources Limited explores for, develops, and produces natural resources in the Americas, the Asia Pacific, and Europe. Private Advisor Group LLC bought a new stake in shares of Teck Resources during the third quarter worth $200,000.